Cédric Bories

Title: Cédric Bories: Innovator in Azaindole Derivatives

Introduction

Cédric Bories is a notable inventor based in Jacou, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as inhibitors for specific kinase activities. With a total of 4 patents to his name, Bories continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Among his latest patents, Bories has focused on azaindole derivatives and their use as ERK kinase inhibitors. The present invention concerns a compound of formula (I) or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity, in particular ERK2 activity. This work highlights his commitment to advancing therapeutic options in the medical field.

Career Highlights

Throughout his career, Cédric Bories has worked with prominent organizations such as Agv Discovery and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Muriel Gelin and Jean-François Guichou. Their collaborative efforts have further enriched the research environment in which Bories operates.

Conclusion

Cédric Bories stands out as an innovative inventor in the realm of medicinal chemistry, particularly with his work on azaindole derivatives. His contributions are paving the way for new therapeutic advancements.